Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Acute COPD Exacerbation
NCT00789997Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2008
- Primary completion
- Aug 2011
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in chronic obstructive pulmonary disease (COPD), sponsored by Ottawa Hospital Research Institute. Started Nov 2008; status: completed.
02
Drugs
etanercept
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00789997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789997.